MDMA Pharmacokinetics
Investigator: Rudolf Brenneisen, PhD University of Bern, Switzerland Contact: br> Completed and published, just a few subjects. Also see the details and references section.
MDMA
MDMA Neurotoxicity Study
Investigators: Una McCann, MD, George Ricaurte, MD, PhD Johns Hopkins University – Baltimore, Maryland Sponsor:NIH PET scan study, MDMA Neurotoxicity, MDMA Users vs. Control Group. MAPS Commentary …
Psilocybins Effects on Cognition
Investigator: Manfred Spitzer, MD, PhD et al. Psychiatrische Universitats Klinic, Heidelberg, Germany Human clinical study, completed and published. More psilocybin research in Germany Spitzer M, et al. …
Human Psychedelic Research: A Historical And Sociological Analysis
Human Psychedelic Research: A Historical And Sociological Analysis Undergraduate Thesis for the Degree of Bachelor of Arts in Natural Sciences (History and Philosophy of Science) by Luke Williams, April …
FY 1998 Financial Report
You can read this report in its original form here. MAPS IRS Form 990 for 1998 in PDF format Fiscal Year June 1, 1997 — May 31, 1998 (FY 97-98) was a strong year for MAPS with a combination of important …
Families Who Value Psychedelics
In this section of the Rites of Passage project, families share their experiences creating their own contexts for psychedelics and marijuana. Just as each family is unique, each of the following accounts …
FY 1996 Financial Report
This past fiscal year, which ran from June 1, 1995 to May 31, 1996, was MAPS' tenth and most successful ever in terms of both fund-raising and membership. I believe that at least part of this increasing …
Psilocybin’s Effects on Cognition
Investigator: Manfred Spitzer, MD, PhD et al. Psychiatrische Universitats Klinic, Heidelberg, Germany Human clinical study, completed and published. More psilocybin research in Germany Spitzer M, et al. …
A Dose/Response Human Pilot Study – Safety and Efficacy of MDMA in Modification of Physical Pain and Psychological Distress in End-Stage Cancer Patients
[This is not the current version of this protocol] Version 4.1 August 22, 1995 A DOSE/RESPONSE HUMAN PILOT STUDY – SAFETY AND EFFICACY OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) IN MODIFICATION OF PHYSICAL …
FY 1994 Financial Report
You can read this report in its original form here. Total Income for FY 93-94 was $106,650.48. There you have it, MAPS' financial report for FY 93-94. MAPS continues to grow as does its research agenda, …
FY 1993 Financial Report
At the beginning of this fiscal year, MAPS had about 350 members and $897 in the bank. By the end of the fiscal year, MAPS' membership had doubled to 707 and its balance was $46,066 (consisting of …
FY 1992 Financial Report
You can read this report in its original form here. MAPS' total income in FY 91-92 was $28,859.55. The following categories had no expenditures this fiscal year. Public Relations/Ads, Salaries, Grants, …
